Mirna Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of micro ribonucleic acid (RNA)-based oncology therapeutics. The Company is developing mimics of naturally occurring microRNAs that are designed to restore the tumor suppressor activity and aid appropriate anti-tumor immune response. This approach is known as microRNA replacement therapy. Its lead product candidate, MRX34,

  Salman Aziz 12 hrs $CERU(Cerulean Pharma) I do not usually suggests stocks to buy below a dollar, but this one is an exception. CERU recently has experienced an increased buyer’s interest, since the company announced they are currently seeking a buyer. The stock closed very strong on February 2, 2017 trading session at 0.93,

FaisamTrader, a stock trading, alerting, and mentoring company working out of Toronto, On Canada. We have over 50 000 hours of stock trading and charting experience and we believe we will never know everything. In order to remain close to knowing everything you have to keep learning, and not a single day goes by where

As a new month rolls around it usually means new stocks to turn your attention to. This is a list of the stock I believe will do really well in the month of February 2017. The goal of this post is to give you an idea of what a bullish stock looks like, so in

$HMNY $drys $cjjd $rgse $aezs — FaisamTrader (@FaisamTrader) Jan. 31 at 01:50 PM

$dgly $eyeg $eses $rgse — FaisamTrader (@FaisamTrader) Jan. 30 at 10:09 AM

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. Its lead product candidate includes ICT-107, a dendritic cell (DC) vaccine that is in Phase III clinical trials for the treatment of glioblastoma multiforme (GBM). The company is also developing other therapeutic DC vaccines, such as ICT-140

SAExploration Holdings, Inc., an oilfield services company, provides seismic data acquisition and logistical support services to the oil and gas industry in North and South America, and Southeast Asia. Its seismic data acquisition services include program design, planning and permitting, camp services, survey, drilling, recording, reclamation, and in-field processing. The company acquires 2D, 3D, time-lapse

Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company primarily focuses on the development of three drug candidates, including

The reason we teach and trade stocks is not just to make money, but to be the best at what we do. Being the best doesn’t always mean if you make the most money, because how much money you make is totally relevant to how much you are trading with, when you started and what